Cancer Research Institute commits $2.5M to fund postdoc fellowships

Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eight
NCI to remain intact, but its finances are uncertain; FDA is spared big cuts

Confidential Trump administration budget documents show that the upcoming FY26 Budget Request will radically cut about $50 billion out of the U.S. Department of Health and Human Services, reshuffling agency components, and slashing the number of NIH institutes and centers to just eight.

Trump administration says Harvard funding freezes will spare affiliated hospitals

Harvard University lawyers rejected the Trump administration’s demand to change the school’s leadership, student disciplinary policies, admissions and hiring, and end diversity, equity, and inclusion practices.

April 18, 2025

Vol.51 No.15

Podcast

In The Headlines: Private funding can’t replace federal funding—but it can help

In the absence of the federal funding, cancer research will be leaning on private funders. But few private funders have the freedom to ask fundamental questions—questions whose answers may not have an immediate clinical impact but can dramatically advance scientific knowledge.

April 09, 2025

Vol.51 No.13

Funding Opportunities

The Stephenson Global Prize and Stephenson Global Scholar Grants calls for nominations, letters of intent

The Stephenson Global Pancreatic Cancer Research Institute, established to advance early detection, innovative treatments, and groundbreaking research for pancreatic cancer, has launched a call for nominations and Letters of Intent for two award opportunities.

March 14, 2025

Vol.51 No.10

Funding Opportunities

Cancer Grand Challenges announces new focus areas for research funding

Global research initiative Cancer Grand Challenges announced on March 5 seven new challenges which it deems to be among the biggest questions in cancer, offering international researchers the chance to form teams to apply for up to $25 million (or £20 million) in funding to take them on.

March 07, 2025

Vol.51 No.09

Funding Opportunities

DOD Peer Reviewed Cancer Research Program announces anticipated funding opportunities

The FY25 Defense Appropriations Act is anticipated to provide funding for the Peer Reviewed Cancer Research Program to support innovative, high-impact cancer research.

February 28, 2025

Vol.51 No.08

Cancer Research Institute commits $2.5M to fund postdoc fellowships

YOU MAY BE INTERESTED IN

Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eight
NCI to remain intact, but its finances are uncertain; FDA is spared big cuts

Trump administration says Harvard funding freezes will spare affiliated hospitals

In The Headlines: Private funding can’t replace federal funding—but it can help

The Stephenson Global Prize and Stephenson Global Scholar Grants calls for nominations, letters of intent

Cancer Grand Challenges announces new focus areas for research funding

DOD Peer Reviewed Cancer Research Program announces anticipated funding opportunities

Renew today!

Subscriber content

Never miss an issue!

Login

Cancer Research Institute commits $2.5M to fund postdoc fellowships

YOU MAY BE INTERESTED IN

Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eightNCI to remain intact, but its finances are uncertain; FDA is spared big cuts

Trump administration says Harvard funding freezes will spare affiliated hospitals

In The Headlines: Private funding can’t replace federal funding—but it can help

The Stephenson Global Prize and Stephenson Global Scholar Grants calls for nominations, letters of intent

Cancer Grand Challenges announces new focus areas for research funding

DOD Peer Reviewed Cancer Research Program announces anticipated funding opportunities

Never miss an issue!

Login

Trump administration seeks to slash NIH by roughly 40% as 27 institutes and centers are whittled down to eight
NCI to remain intact, but its finances are uncertain; FDA is spared big cuts